If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDp Poland Regulatory News (DPP)

Share Price Information for Dp Poland (DPP)

Share Price is delayed by 15 minutes
Get Live Data
7.00    0.00 (0.00%)
Bid:
6.50
Ask:
7.50
Spread: 1.00 (15.385%)
Market Cap: £66.08m
DPP Live PriceLast checked at - London Stock Exchange

Intraday Dp Poland Share Chart

Holding(s) in Company

13 Feb 2015 16:39

RNS Number : 9233E
DP Poland PLC
13 February 2015
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

DP POLAND PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

x

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

HARGREAVE HALE LIMITED

4. Full name of shareholder(s)  (if different from 3.):iv

DISCRETIONARY CLIENTS

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

12 FEBRUARY 2015

6. Date on which issuer notified:

13 FEBRUARY 2015

7. Threshold(s) that is/are crossed orreached: vi, vii

17%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Indirect

Direct xi

Indirect xii

Direct

Indirect

GB00B3Q74M51

16,222,832

16,222,832

16,272,832

16,272,832

17.0507%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 

16,272,832

17.0507%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

15,283,333 of these shares are held for unit trusts operated by Marlborough Fund Managers Ltd, for whom Hargreave Hale Ltd manages the portfolio of investments on a discretionary basis. The remaining shares are held for other discretionary clients.

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

David Clueit

15. Contact telephone number:

01253 754739

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLLFVRFDIVLIE
Date   Source Headline
22nd Sep 20237:00 amRNSNotice of Interim Results
28th Jul 202312:21 pmRNSResult of AGM
28th Jul 20237:00 amRNSBoard Changes & Related Party Transaction
21st Jul 20237:00 amRNSTrading Update
4th Jul 20237:00 amRNSPosting of Annual Report & Notice of AGM
3rd Jul 20237:00 amRNSIssue of Options
30th Jun 20237:00 amRNSFinal Results
30th May 202312:02 pmRNSTrading Update
25th May 202311:55 amRNSExercise of Options & TVR
20th Apr 20237:00 amRNSTrading Update
10th Mar 202311:00 amRNSBoard Changes
20th Jan 20237:00 amRNSBoard Changes
17th Jan 20237:00 amRNSTrading Update
30th Dec 20227:00 amRNSBoard Changes
10th Nov 20224:09 pmRNSIssue of Options, Exercise of Options & TVR
9th Nov 20227:00 amRNSBoard Changes
28th Sep 20227:00 amRNSInterim Results and Trading Update
23rd Sep 202212:00 pmRNSNotice of Interim Results
12th Sep 20223:50 pmRNSHolding(s) in Company
30th Aug 20227:00 amRNSProposed Board Changes and Issue of Options
19th Aug 20226:02 pmRNSResult of Placing & Subscriptions
19th Aug 20225:05 pmRNSClose of Bookbuild
18th Aug 20224:37 pmRNSProposed Fundraise
10th Aug 202212:28 pmRNSHolding(s) in Company
1st Aug 20227:00 amRNSBoard Changes and Issue of Options
29th Jul 202212:13 pmRNSCompletion of Acquisition
15th Jul 202211:52 amRNSResult of AGM
15th Jul 20227:00 amRNSTrading Update
17th Jun 20227:00 amRNSPosting of Annual Report and Notice of AGM
16th Jun 20225:37 pmRNSHolding(s) in Company
16th Jun 202212:02 pmRNSDirector/PDMR Shareholding
15th Jun 20227:05 amRNSAcquisition, Board Changes & Issue of Options
15th Jun 20227:00 amRNSFinal Results and Trading Update
21st Apr 20227:00 amRNSTrading Update
5th Apr 20227:00 amRNSBoard Changes
4th Apr 20223:33 pmRNSIssue of Equity and Total Voting Rights
16th Mar 202210:24 amRNSHolding(s) in Company
9th Mar 20227:00 amRNSNotification of Trading Update
1st Mar 20227:00 amRNSGrant of Options, Equity Issue, PDMR Dealing & TVR
18th Jan 20227:00 amRNSExercise of Options & Total Voting Rights
17th Jan 20227:00 amRNSTrading Update
31st Dec 20217:00 amRNSNotice of Trading Update
2nd Dec 20217:00 amRNSDirector Change
9th Nov 20214:27 pmRNSChange of Registered Office
9th Nov 20214:24 pmRNSHolding(s) in Company
3rd Nov 20219:30 amRNSResult of Fundraising
3rd Nov 20217:00 amRNSClose of Bookbuild
2nd Nov 202110:13 amRNSProposed Fundraising
1st Sep 20217:00 amRNSNotice of Interim Results
19th Aug 20214:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.